| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/03/2023 | 8.12% | Rosenblatt | $140 → $150 | Maintains | Buy |
| 07/27/2022 | 18.94% | Raymond James | $170 → $165 | Maintains | Outperform |
| 07/22/2022 | 8.12% | Rosenblatt | $165 → $150 | Maintains | Buy |
| 03/22/2022 | 22.54% | Raymond James | → $170 | Upgrades | Market Perform → Outperform |
| 02/02/2022 | 18.94% | Rosenblatt | $195 → $165 | Maintains | Buy |
| 07/28/2021 | 40.56% | Rosenblatt | $165 → $195 | Maintains | Buy |
| 05/26/2021 | 8.12% | Benchmark | $137 → $150 | Maintains | Buy |
| 05/06/2021 | 18.94% | Rosenblatt | $150 → $165 | Maintains | Buy |
| 02/03/2021 | 8.12% | Rosenblatt | $120 → $150 | Maintains | Buy |
| 01/26/2021 | -1.97% | Truist Securities | $120 → $136 | Maintains | Buy |
| 07/24/2020 | -13.5% | Rosenblatt | $100 → $120 | Maintains | Buy |
| 07/24/2020 | -20.71% | Benchmark | $105 → $110 | Maintains | Buy |
| 07/15/2020 | -27.92% | SunTrust Robinson Humphrey | $98 → $100 | Maintains | Buy |
| 05/21/2020 | -42.33% | SunTrust Robinson Humphrey | $70 → $80 | Maintains | Buy |
| 05/21/2020 | -27.92% | Rosenblatt | $80 → $100 | Maintains | Buy |
| 04/22/2020 | -56.03% | Benchmark | $10 → $61 | Maintains | Overweight |
| 04/14/2020 | -49.54% | SunTrust Robinson Humphrey | $102 → $70 | Maintains | Buy |
| 04/09/2020 | -42.33% | Rosenblatt | $110 → $80 | Maintains | Buy |
| 02/19/2020 | -30.08% | Baird | → $97 | Initiates Coverage On | → Outperform |
| 02/05/2020 | -27.92% | Benchmark | $90 → $100 | Maintains | Buy |
| 08/15/2019 | -27.92% | Rosenblatt | → $100 | Initiates Coverage On | → Buy |
| 08/12/2019 | -33.68% | SunTrust Robinson Humphrey | $85 → $92 | Maintains | Buy |
| 04/22/2019 | — | SunTrust Robinson Humphrey | Upgrades | Hold → Buy | |
| 09/26/2018 | — | SunTrust Robinson Humphrey | Downgrades | Buy → Hold | |
| 06/15/2018 | — | Benchmark | Upgrades | Hold → Buy |
What is the target price for Manhattan Associates (MANH)?
The latest price target for Manhattan Associates (NASDAQ: MANH) was reported by Rosenblatt on February 3, 2023. The analyst firm set a price target for $150.00 expecting MANH to rise to within 12 months (a possible 8.12% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Manhattan Associates (MANH)?
The latest analyst rating for Manhattan Associates (NASDAQ: MANH) was provided by Rosenblatt, and Manhattan Associates maintained their buy rating.
When is the next analyst rating going to be posted or updated for Manhattan Associates (MANH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Manhattan Associates, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Manhattan Associates was filed on February 3, 2023 so you should expect the next rating to be made available sometime around February 3, 2024.
Is the Analyst Rating Manhattan Associates (MANH) correct?
While ratings are subjective and will change, the latest Manhattan Associates (MANH) rating was a maintained with a price target of $140.00 to $150.00. The current price Manhattan Associates (MANH) is trading at is $138.73, which is out of the analyst's predicted range.